Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >ABHD10 Protein, Human, Recombinant (aa 53-306, His)
ABHD10 Protein, Human, Recombinant (aa 53-306, His)
  • ABHD10 Protein, Human, Recombinant (aa 53-306, His)

ABHD10 Protein, Human, Recombinant (aa 53-306, His) NEW

Price $812
Package 100μg
Min. Order:
Supply Ability: 10g
Update Time: 2025-08-29

Product Details

Product Name: ABHD10 Protein, Human, Recombinant (aa 53-306, His) Supply Ability: 10g
Release date: 2025/08/29

Product Introduction

Bioactivity

NameABHD10 Protein, Human, Recombinant (aa 53-306, His)
DescriptionMycophenolic acid (MPA), the active metabolite of the immunosuppressant mycophenolate mofetil (MMF), is primarily metabolized by glucuronidation to a phenolic glucuronide (MPAG) and an acyl glucuronide (AcMPAG). It is known that AcMPAG, which may be an immunotoxic metabolite, is deglucuronidated in human liver. AcMPAG deglucuronidation activity was detected in both human liver cytosol (HLC) and microsomes (HLM). By purification from HLC with column chromatographic purification steps, the enzyme responsible for AcMPAG deglucuronidationis identified as α/β hydrolase domain containing 1 (ABHD1). Recombinant ABHD1 expressed in Sf9 cells efficiently deglucuronidated AcMPAG with a K(m) value of 1.7 ± 1.2 μM, which was similar to those in HLM, HLC, and human liver homogenates (HLH). Immunoblot analysis revealed ABHD1 protein expression in both HLC and HLM. The AcMPAG deglucuronidation by recombinant ABHD1, HLC, and HLH were potently inhibited by AgNO(3), CdCl(2), CuCl(2), PMSF, bis-p-nitrophenylphosphate, and DTNB. The CL(int) value of AcMPAG formation from MPA, which was catalyzed by human UGT2B7, in HLH was increased by 1.8-fold in the presence of PMSF. Thus, human ABHD1 would affect the formation of AcMPAG, the immunotoxic metabolite.
StorageShipping with blue ice/Shipping at ambient temperature.
KeywordsABHD-10 | ABHD 10

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

Recommended supplier

Product name Price   Suppliers Update time
$498.00/100μg
VIP6Y
TargetMol Chemicals Inc.
2025-08-28
$1830.00/1mg
VIP2Y
TargetMol Chemicals Inc.
2025-08-21
$0.00/10mg
VIP8Y
Guangzhou PI PI BIOTECH INC
2022-04-23

TargetMol Chemicals Inc.

4YR United StatesUnited States
  • Since: 2011-01-07
  • Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY